News

The assays are used to determine hemoglobin variants and diabetes risk, using Bruker´s Matrix-Assisted Laser Desorption Ionization (MALDI) Biotyper platform for clinical mass spectrometry and based on intellectual

BD Simplist prefilled injectables are designed to enhance patient care and safety by minimizing the number of steps in the traditional vial and syringe injection sequence, cutting the

Of €3.6m, €2.7m will be used for balance sheet restructuring and €0.9m will finance the additional production facilities. Piramida CEO Kresimir Hlede said that the investment would mark

The multi-centre study will determine a recommended NEOD001 dose for testing in Phase 2 trials. Prothena president and chief executive officer Dale Schenk said preclinical data indicated NEOD001’s

The collaboration will focus on developing small molecule therapeutics targeting a janus kinase (JAK) family member, TYK2. Sareum CEO Dr. Tim Mitchell said, "The agreement with SRI gives

According to the deal, Novo Nordisk has access to the Kymouse HK and Kymouse HL transgenic human antibody mouse strains, the combination of which are used to create

Lonza will manufacture BNC101 at Slough facility in the UK. Bionomics CEO and managing director Dr Deborah Rathjen said, "The start of manufacturing activities for BNC101 signals a

Alitair provided additional details regarding its ‘398 patent specific to formulations of benzonatate. At present, benzonatate is the only non-narcotic prescription cough product available, according to the company

The novel chemical entity XEN402 is designed to inhibit the SCN9A sodium channel. Teva Pharmaceutical Industries has exclusive worldwide license to XEN402 that earlier demonstrated to relieve from